Colorado Has a Chance to Get Ibogaine Policy Right

Colorado is on the verge of becoming the first U. state to offer legal ibogaine services through regulated healing centers. This is a historic moment — but it comes with a critical question: How much medical oversight should be required?

The Opportunity Following the passage of Proposition 122 in 2022 and Senate Bill 23-290 in 2023, Colorado's Natural Medicine Advisory Board has recommended adding ibogaine to the list of regulated substances alongside psilocybin and psilocin. If approved, Coloradans could access ibogaine therapy without traveling to Mexico, Costa Rica, or other international destinations. This is what advocates have been fighting for: legitimate, legal access to a treatment that has shown remarkable results for opioid addiction, PTSD, depression, and trauma. The Challenge But here's the catch: Ibogaine is not like psilocybin.

While psilocybin therapy has been extensively studied in recent FDA trials and has a relatively manageable safety profile, ibogaine presents unique medical challenges: Cardiac risks: Ibogaine can prolong the QT interval (the heart's electrical recharging time), which in rare cases can lead to fatal arrhythmias Drug interactions: Ibogaine interacts with many common medications, including SSRIs, benzodiazepines, and stimulants Individual variation: Response to ibogaine varies dramatically based on genetics, medical history, and current health status A recent opinion piece in Colorado Newsline argues that ibogaine demands a comparable regulatory framework to FDA-approved drugs — at least until it receives full federal approval. The piece emphasizes the need for: Pre-treatment medical screening (EKG, blood work, medication review) Cardiac monitoring during treatment (continuous EKG for 24-48 hours) Trained medical staff on-site (physicians or nurse practitioners) Evidence-based protocols (dosing, preparation, integration) Liability protections (risk mitigation strategies for providers) Why This Matters The stakes are high. If Colorado gets this right, it could become the model for ibogaine regulation nationwide. If it gets it wrong — if a patient dies due to inadequate medical oversight — we risk another round of sensationalized headlines and policy backlash.

We've seen this before. In the 1990s and early 2000s, unregulated ibogaine providers operated in informal settings without medical supervision. Several deaths occurred — not because ibogaine itself is inherently dangerous, but because proper medical screening and monitoring weren't in place .

state to offer legal ibogaine services through regulated healing centers.

The MindScape Model This is exactly why MindScape Retreat has always operated under full medical supervision at our facility in Cozumel, Mexico. Every patient undergoes: Comprehensive pre-screening (EKG, blood panel, medication review, psychological assessment) Cardiac monitoring during treatment (continuous EKG + pulse oximetry) On-site physicians and nurses 24/7 Individualized dosing based on medical history and body chemistry Post-treatment integration support (therapy, follow-up care) We don't cut corners. We don't treat ibogaine like a recreational psychedelic.

We treat it like the powerful medicine it is. And because we operate in Cozumel — where ibogaine is legal and unscheduled — we can offer this level of care without waiting for U. policy to catch up . What Colorado Can Learn If Colorado truly wants to become the gold standard for ibogaine access, it should look at what's already working: Mexico's legal ibogaine clinics — Over 50 facilities operate with medical oversight, many with excellent safety records New Zealand's medical model — Ibogaine is available through licensed healthcare providers with strict protocols Brazil's harm reduction approach — Ibogaine is legal and increasingly integrated into addiction treatment programs The key is balance: Make ibogaine accessible, but don't compromise on safety.

The Path Forward Colorado has three options: Option 1: Minimal Oversight (Risky) Allow healing centers to administer ibogaine with minimal medical requirements. This would maximize access but increase risk — especially for patients with undiagnosed cardiac conditions or medication interactions. Option 2: Medical Model (Recommended) Require healing centers to have licensed medical professionals on-site, conduct pre-screening, and provide cardiac monitoring during treatment. This is the MindScape model — and it works.

Option 3: Physician-Only (Restrictive) Limit ibogaine administration to licensed physicians in clinical settings. This would be the safest option but would dramatically limit access — most doctors aren't trained in ibogaine therapy. Our vote: Option 2. Medical oversight without excessive barriers to access.

The Bigger Picture Colorado's decision will ripple across the country. Oregon, Utah, Washington, and Texas are all considering ibogaine legislation. If Colorado demonstrates that ibogaine can be offered safely within a regulated framework , other states will follow. If Colorado fails — if deaths occur due to inadequate oversight — we risk setting the ibogaine movement back by a decade.

What This Means for Patients If you're considering ibogaine treatment, here's what you need to know: Don't wait for Colorado. Ibogaine is available NOW at licensed clinics around the world — including MindScape Retreat in Cozumel. Don't compromise on safety. Choose a clinic with: Licensed medical staff on-site Pre-treatment screening (EKG, blood work) Cardiac monitoring during treatment Integration support (therapy, follow-up) Don't fall for underground providers.

Just because someone has access to ibogaine doesn't mean they know how to administer it safely. Medical training matters. Conclusion Colorado has a historic opportunity to get ibogaine policy right. With proper medical oversight, evidence-based protocols, and a commitment to patient safety, Colorado can become the model for ibogaine access nationwide.

But patients don't have to wait. MindScape Retreat has been offering medically supervised ibogaine treatment for years — with on-site doctors, cardiac monitoring, and integration support. If you or a loved one is struggling with addiction, PTSD, or trauma, don't wait for policy to change. Healing is available now.

Ready to start your healing journey? Visit MindScape Retreat or call +52-XXX-XXXX-XXXX to speak with our intake team. MindScape Retreat is a licensed medical facility in Cozumel, Mexico, specializing in ibogaine therapy for addiction, PTSD, and trauma. Our team includes on-site physicians, nurses, and integration therapists.